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Abstract
The aim of this study was to examine infant feeding and the long-chain polyunsaturated fatty acid (LCPUFA)
concentration of breast milk and formulas in relation to infant development. The prospective Pregnancy,
Infection and Nutrition Study (n = 358) collected data on breastfeeding, breast milk samples and the formulas
fed through 4 months post-partum. At 12 months of age, infants’ development was assessed (Mullen Scales of
Early Learning). Linear regression was used to examine development in relation to breastfeeding, breast milk
docosahexaenoic acid (DHA) and arachidonic acid (AA) concentration, and DHA and AA concentration from
the combination of breast milk and formula. The median breast milk DHA concentration was 0.20% of total
fatty acids [interquartile range (IQR) = 0.14, 0.34]; median AA concentration was 0.52% (IQR = 0.44, 0.63).
Upon adjustment for preterm birth, sex, smoking, race and ethnicity and education, breastfeeding exclusivity was
unrelated to development. Among infants exclusively breastfed, breast milk LCPUFA concentration was not
associated with development (Mullen composite, DHA: adjusted b = -1.3, 95% confidence interval: -10.3, 7.7).
Variables combining DHA and AA concentrations from breast milk and formula, weighted by their contribution
to diet, were unassociated with development. We found no evidence of enhanced infant development related to
the LCPUFA content of breast milk or formula consumed during the first four post-natal months.
Keywords: arachidonic acid, breast milk, docosahexaenoic acid, infant feeding, polyunsaturated fatty acids,
breastfeeding.
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Introduction
The role of long-chain polyunsaturated fatty acids
(LCPUFAs) in brain development has long been
of interest. Fatty acids are important constituents of
cell membranes, and docosahexaenoic acid (DHA) in
particular accumulates in high concentration in the
developing brain (Kishimoto et al. 1969, Sun & Sun
1972). DHA and other LCPUFAs like arachidonic
acid (AA) are available to infants through breast milk
and supplemented formulas.
LCPUFA supplementation seems to accelerate
some developmental domains like visual acuity and
general mental development among preterm infants
(Carlson et al. 1996; Fewtrell et al. 2004; Clandinin
et al. 2005; Makrides et al. 2009), but the degree to
which LCPUFAs are associated with other aspects of
development like language or motor development
and among term infants is less clear (Scott et al. 1998;
Makrides et al. 2000; Auestad et al. 2001; O’Connor
et al. 2001; Fewtrell et al. 2002). Most studies have
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focused on general mental or motor development
or early visual acuity rather than later-develop-
ing components of language or visual reception. A
randomized design can be extremely advantageous,
but studies comparing infants fed supplemented
formulas with breastfed infants present a problem if
they do not effectively control for factors associated
with the choice to breastfeed vs. formula feed because
such factors also influence development. Most trials
supplementing mother’s milk use an intent-to-treat
analysis, comparing groups rather than the LCPUFAs
concentration reaching individuals; thus, they do
not consider variability in exposure from maternal
or infant diet outside the supplement. Most US chil-
dren are introduced to formula during infancy,
and by 6 months of age, only 13% are exclusively
breastfed (CDC 2010). Both breast milk and infant
formulas can be significant sources of LCPUFAs,
but the amount contributed may vary considerably
according to feeding method (breast vs. formula)
and composition of formula. Furthermore, studies
of complex feeding patterns observed in the
general population that distinguish the psycho-
social contribution of breastfeeding from breast
milk and formula LCPUFAs are lacking in the
literature.
We address three questions. First, is the extent
of breastfeeding during the first four post-natal
months associated with visual reception, receptive
and expressive language, motor skills and overall
cognitive development at 12 months of age? Second,
among exclusively breastfed infants, is the LCPUFA
concentration of breast milk associated with devel-
opment? Third, is the LCPUFA concentration
over the first four post-natal months (derived
from individual combinations of breast milk and




Data were from the Pregnancy, Infection and Nutri-
tion (PIN) Study and its post-natal follow-up com-
ponents, PIN Postpartum and PIN Babies. The PIN
Study assessed the association of prenatal nutrition,
lifestyle and infection with preterm birth using data
from medical records, interviews and specimens pro-
vided during pregnancy (Savitz et al. 1999). Women
were recruited from among those attending prenatal
clinics at less than 20 weeks of pregnancy at the Uni-
versity of North Carolina Hospitals between January
2001 and June 2005. Women were ineligible if they
were pregnant with multiple fetuses, could not com-
municate in English, were under the age of 16 years,
had no access to a telephone or were intending to go
elsewhere for future care or delivery. The PIN Post-
partum Study assessed behaviours associated with
high gestational weight gain and post-partum weight
retention through data collected during home
interviews around 4 and 12 months post-partum
(Evenson et al. 2009). Women (n = 1 169) were eli-
gible for PIN Postpartum if they completed the PIN
Study, agreed to be contacted after delivery and
lived in the study area. Medical constraints (n = 24),
inability to re-contact (n = 207) or schedule (n = 62)
and refusal (n = 187) resulted in 689 women who
participated in a visit scheduled in the fourth post-
partum month. Before the 12-month data collection
Key messages
• Infants who were exclusively or almost exclusively breastfed for the first 4 months exhibited more advanced
development at 12 months than exclusively formula-fed infants, but this association was attenuated after
controlling for key confounders.
• The docosahexaenoic acid (DHA) content of breast milk, or breast milk and formula combined, was not
associated with infant development.
• Future studies should consider individual exposures using the actual concentrations of fatty acids infants are
exposed to, as a complement to analyses that compare treatment groups, to better clarify whether there are
benefits of DHA supplementation to infants born at term.
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visit, 45 became pregnant again and were ineligible
to continue, 62 were unreachable, 29 moved from
the study area and 20 requested to leave the study.
The PIN Babies Study assessed the association
between the prenatal and early post-natal environ-
ment and child development. Infants’ development
was assessed during the PIN Postpartum home visits.
In January 2004, infants of participating women
became eligible for the PIN Babies protocol. Among
the remaining 408 eligible maternal–infant pairs,
some did not participate in the Mullen developmen-
tal assessment because the child was not present
during the data collection (n = 11, e.g. the mother
completed the interview at her workplace), the child
was asleep, sick or fussy (n = 21), the mother refused
the child’s participation (n = 8), there was not
enough time during the visit (n = 3) or various other
reasons (n = 7). The university’s institutional review
board approved all protocols; all participants pro-
vided written informed consent. Infants who com-
pleted at least part of the Mullen at 12 months were
included in this analysis.
Exposure measurement
At the home visit at 4 months post-partum, women
provided information about the number of times per
day the infant was breastfed or fed formula or other
foods for each preceding month. Women who were
still breastfeeding were asked to use a breast pump at
around 10 am on the day of the visit to provide three
1.5-mL tubes of milk for storage at -80°C. Samples
collected before April 2005 were analysed by the
Collaborative Studies Clinical Laboratory at the
University of Minnesota Medical Center, Fairview
(Minneapolis, MN, USA). This laboratory was unable
to analyse a second batch, so samples collected
later were analysed at the Clinical Nutrition Research
Center of the University of North Carolina (Chapel
Hill, NC, USA). Fatty acid extraction used the
method of Bligh & Dyer (1959). The individual fatty
acids were identified by comparison with authentic
standards (Nu Chek Prep, Elysian, MN, USA). Data
were analysed using Perkin Elmer Totalchrom Chro-
matography Software, version 6.2 (Somerset, NJ,
USA).
Feeding method was classified for each month of
the first 4 months. Although feeding methods could
change within a particular month, women were asked
to consider the predominant method for the month.
Infants who were breastfed for all feedings per day
were considered exclusively breastfed. Infants who
were breastfed and also had one formula feeding per
day were considered almost exclusively breastfed.
Infants who were fed formula for all daily feedings
were considered exclusively formula fed. All others
were considered partially breastfed. For the 4-month
period as a whole, infants who were exclusively or
almost exclusively breastfed all months or exclusively
formula fed all months were classified accordingly.All
others were classified as partially breastfed for the
4-month period as a whole.
For each month of exclusive or almost exclusive
breastfeeding, breast milk LCPUFA concentrations
were assigned as the exposure value. For each month
of formula feeding, the names of up to two formulas
were recorded. The fatty acid concentration for each
formula was assigned using data from the US Depart-
ment of Agriculture Nutrient Database for Standard
Reference (US Department of Agriculture 2008). If
more than one formula was fed in a month, the mean
value for the two most fed was used.
We created a variable reflecting the combination
of DHA and AA concentrations in breast milk and
USDA-based concentrations of DHA and AA in the
formula(s) for each month. To account for variation
in feeding method across months, the composite
variable was weighted by the relative contribution of
breast milk and formula for each month. Each
month of partial breastfeeding was assigned half
the laboratory value for the breast milk plus half
the average formula value for that month. DHA and
AA exposure variables for all 4 months com-
bined were calculated by summing the monthly
values:
exposure k k
Fb m m ff
F
m














where m = month since birth, m = concentration of the
fatty acid of interest in breast milk (b) or infant
formula (f) (units: % of total fatty acids), k = feeding
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pattern in m (1, if exclusive or almost exclusive breast-
feeding; 0.5, if partial breastfeeding; 0, if formula
feeding), F = number of formulae fed (Fi  2) and
f = formula product.
Outcome measurement
The Mullen was administered by four trained staff in
the home when infants reached 12 months of age
{inter-rater reliability = 0.83 [95% confidence interval
(CI): 0.70, 0.93] } (Mullen 1995). The Mullen assesses
cognitive functioning on five subscales: visual recep-
tion, fine motor, receptive language, expressive lan-
guage and gross motor. Raw scores were converted
to age-specific t-scores and four subscales (all but
gross motor) were summed per the manual to create
the Early Learning Composite Score (composite)
(Mullen 1995). Examples of the abilities assessed for
this age include standing, looking for objects, stacking
blocks, understanding gestures with commands and
jabbering with inflection. Scores were not adjusted for
gestational age at birth because the procedure recom-
mended in the Mullen manual overcorrected scores
for preterm infants. However, an indicator of preterm
status was included in models.
Covariate measurement
Data on maternal age, education and other demo-
graphic and lifestyle covariates were obtained via
telephone in prenatal weeks 17–22. Around 20 weeks
gestation, women completed the State-Trait Anxiety
Inventory (Spielberger 1983). Parity was defined as
the number of prior live or stillbirths. Gestational age
was based on ultrasound if done before 22 weeks or
the date of the last menstrual period from the hospital
record. We defined preterm birth as less than 37 com-
pleted weeks’ gestation. At the first post-natal visit,
women reported current smoking and family income
and completed the Edinburgh Postnatal Depression
Scale (EPDS) (Cox et al. 1987).
Statistical analysis
We built three sets of linear regression models: (1)
Breastfeeding models: compared with exclusively
formula-fed infants, we assessed whether the degree
of breastfeeding over the first four post-partum
months (exclusive/almost exclusive, partial or formula
feeding) was associated with Mullen subscale and
composite scores; (2) Breast milk models: among
infants exclusively breast fed through the first
4 months, we examined the association between the
breast milk DHA and AA concentration and Mullen
scores; and (3) Combined models: we evaluated total
DHA and AA represented by the constructed vari-
ables that incorporated the proportional concentra-
tions of DHA and AA from both formula and breast
milk sources in relation to Mullen scores. For the
breast milk and combined models, we also examined
the DHA : AA ratio.
Possible covariates were identified a priori based
on previous studies, and each was evaluated for
inclusion in adjusted models by selecting those that
changed the exposure variable beta coefficient by
>10% when removed from a model. We evaluated
income (<185, 185–350, >350% of federal poverty
level), education (high school, >high school), mater-
nal age (16–20, 21–30, 31+ years), parity (0, 1+), race
and ethnicity (white non-Hispanic, all others), sex,
preterm birth (<37 weeks gestation), trait anxiety
(tertiles) and depressive symptoms (EPDS 0–9 vs.
10+). Wilcoxon rank-sum, chi-square and t-tests were
used to examine differences in exposure and outcome
distributions across levels of covariates. Multiple
partial F-tests assessed the presence of effect modifi-
cation.All models that examined breast milk included
a variable indicating the laboratory that analysed the
sample, a statistical technique for adjusting for any
differences between laboratories. SAS 9.1 (SAS Insti-
tute, Cary, NC, USA) was used for analyses.
Results
Eighty-nine per cent of women in this sample breast-
fed. The proportions of infants exclusively or almost
exclusively breastfed, partially breastfed and exclu-
sively formula fed are shown in Fig. 1a. By the time of
breast milk collection, 68 of the 358 eligible women
had discontinued breastfeeding, 231 provided a
sample (230 were analyzable), 17 were breastfeeding
but unable to provide a sample, three refused milk
S.A. Keim et al.474
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collection and 39 had exclusively formula fed their
infant. DHA in samples ranged from 0.07% to 1.49%
of total fatty acids [mean = 0.28%, standard deviation
(SD) = 0.22] (Table 1). AA ranged from 0.05% to
1.52% of total fatty acids (mean 0.57%, SD = 0.20).
In general, women who exclusively or almost
exclusively breastfed were more likely to be white,
non-Hispanic, non-smokers, well-educated and
have term infants than those who partially or exclu-
sively formula fed. There were few differences in the
LCPUFA distributions across the covariates, but
DHA concentration varied by parity and laboratory.
No participant characteristics or outcomes were asso-
ciated with which laboratory analysed the samples
(data not shown).
Among infants receiving some formula, the propor-
tion that received LCPUFA-supplemented formulas
each month is shown in Fig. 1b. Only eight were fed
more than one formula in any month, and three were
fed non-supplemented formulas for all 4 months. Six
women could not identify the formula they fed and
were excluded from the combined models. The fatty
acid concentration of formulas ranged from 0.30% to
0.37% for DHA and from 0.50% to 0.67% for AA.
Feedings of other foods were uncommon in this
cohort until 3 months of age when the most common
were cereal (14% were fed cereal one or more times
per day), fruit or vegetables (4%) and juice (4%).
Mullen scores were as expected for a general popu-





Fig. 1. (a) The proportion of infants exclu-
sively or almost exclusively breastfed, partially
breastfed and exclusively formula fed in each
of the first four post-natal months and all
4 months combined. For the whole period,
the partially breastfed group consists of
infants who were at least partially breastfed in
at least 1 month but not exclusively breastfed
for all 4 months. PIN 2001–2006 [from PIN
(1995–2006)] Babies Study. (b) The propor-
tion of formulas supplemented with docosa-
hexaenoic acid (DHA) and arachidonic acid
(AA) over the first four post-natal months
fed to infants not exclusively breastfed. PIN
2001–2006 [from PIN (1995–2006)] Babies
Study.
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mean composite score = 99). Scores were higher
among females (t = -3.5, P < 0.01) and term (t = -2.8,
P < 0.01) infants and those whose mothers were more
educated (t = -2.1, P = 0.04) and non-smokers (t = 2.6,
P = 0.01). Scores among children whose mothers were
still breastfeeding at the time of milk collection but
did not provide a milk sample were not notably dif-
ferent from those who provided samples (t = 0.6,
P = 0.54). Children whose mothers breastfed but had
quit by the time of milk collection scored lower (mean
composite = 96.3, SD = 13.1) than children whose
mothers were still breastfeeding (mean compos-
ite = 101.1, SD = 13.7) (t = 2.5, P = 0.01).
In unadjusted models, infants who were exclusively
or almost exclusively breastfed for the first 4 months
exhibited more advanced development in several
domains compared with infants who were formula fed
(e.g. unadjusted b for composite = 6.2, 95% CI: 1.6,
10.8). However, these differences were consistently
attenuated (adjusted effect estimates for all subscales
were within 3 points of null) upon adjustment for
confounders and were no longer statistically signifi-
cant (a = 0.05) (e.g. adjusted b for composite = 3.7,
95% CI: -1.3, 8.6) (Table 2). Thus, we conclude that
feeding method was not associated with development
once key confounders were included in the analysis.
Among infants exclusively breastfed, breast milk
DHA concentration was not associated with Mullen
scores after adjustment for sex, parity, smoking,
preterm status and laboratory – almost all adjusted
beta coefficients were within 3 points of null and all
CI included the null (e.g. adjusted b for compos-
ite = -1.3, 95% CI: -10.3, 7.7) (Table 3).Although AA
concentration was positively associated with develop-
ment in unadjusted models, especially gross motor
development (beta coefficients were >3 points from
the null for all subscales), the estimates were very
imprecise and almost all CI included the null. Once
confounders were considered, almost all of the effect
estimates were slightly attenuated and all effect esti-
mates were not statistically significant (a = 0.05) (e.g.
adjusted b for gross motor = 9.0, 95% CI: -1.0, 19.0).
Results for the DHA : AA ratio for all scales did not
differ from the null (results not shown). As a result,
we conclude that breast milk DHA content was not
associated with cognitive development because of the
small magnitude of the effect estimates (for DHA)
and the lack of statistical significance (for DHA and
AA).
In the models incorporating combinations of breast
milk and formula DHA and AA concentrations,
neither DHA, AA nor DHA : AA were associated
with Mullen scores – all unadjusted and adjusted
effect estimates were very close to 0 and none were
statistically significant (a = 0.05) (e.g. DHA: adjusted
b for composite = -0.5, 95% CI: -2.7, 1.7; AA:
adjusted b for composite = 0.9, 95% CI: -1.5, 3.4)
(Fig. 2, Table 4, results not shown for DHA : AA).
Table 2. Results from linear regression models for the association between feeding method for the first four post-natal months and Mullen Scales
of Early Learning scores, PIN 2001–2006 [from PIN (1995–2006)] Babies Study
Mullen Scales of Early
Learning
Feeding method* (exclusively formula fed = reference, n = 39)
Exclusively or almost exclusively breastfed (n = 207) Partially breastfed (n = 112)
b (CI) (unadjusted) b (CI) (adjusted)† b (CI) (unadjusted) b (CI) (adjusted)†
Gross motor 1.7 (-2.4, 5.8) 0.9 (-3.5, 5.3) 0.9 (-3.5, 5.3) 0.6 (-3.7, 4.9)
Visual reception 4.4 (0.7, 8.2) 2.4 (-1.7, 6.5) 0.6 (-3.4, 4.7) -0.2 (-4.2, 3.9)
Fine motor 4.6 (0.8, 8.3) 2.5 (-1.6, 6.5) 2.2 (-1.8, 6.3) 1.1 (-2.9, 5.1)
Receptive language 1.2 (-1.6, 3.9) 0.5 (-2.4, 3.5) -1.2 (-4.1, 1.7) -1.5 (-4.4, 1.4)
Expressive language 2.2 (-0.9, 5.3) 1.5 (-1.8, 4.9) 0.4 (-2.9, 3.7) 0.1 (-3.3, 3.3)
Composite 6.2 (1.6, 10.8) 3.7 (-1.3, 8.6) 1.0 (-4.0, 5.9) -0.3 (-5.2, 4.6)
CI, confidence interval. *Infants who were breastfed for all feedings per day for the first four post-natal months were considered exclusively
breastfed. Infants who were breastfed plus up to one formula feeding per day were considered almost exclusively breastfed. Infants who were
fed infant formula for all daily feedings were considered exclusively formula fed. All other infants were partially breastfed. †Adjusted models
include education, race and ethnicity, smoking, infant sex and preterm status.
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Fig. 2. Calculated exposure to docosa-
hexaenoic acid (DHA) from breast milk and
infant formula averaged across 4 months
plotted against Mullen Scales of Early Learn-
ing composite score. +, exclusively or almost
exclusively breastfed; , partially breastfed; D,
exclusively formula fed. PIN 2001–2006
[from PIN (1995–2006)] Babies Study.
Table 3. Results from linear regression models for the association between docosahexaenoic acid and arachidonic acid in breast milk and Mullen




Breast milk DHA (continuous) Breast milk AA (continuous)
b (CI) (unadjusted)*† b (CI) (adjusted)‡ b (CI) (unadjusted)*† b (CI) (adjusted)‡
Gross motor 5.6 (-2.8, 13.9) 3.9 (-4.6, 12.4) 10.6 (0.5, 20.7) 9.0 (-1.0, 19.0)
Visual reception -3.5 (-11.1, 4.1) -2.7 (-10.5, 5.1) 4.3 (-4.7, 13.3) 4.4 (-4.6, 13.3)
Fine motor 2.8 (-4.8, 10.5) 2.3 (-5.2, 9.9) 3.8 (-5.3, 12.8) 1.7 (-7.0, 10.4)
Receptive language 0.7 (-4.5, 5.9) -0.7 (-5.9, 4.5) 3.5 (-2.8, 9.8) 2.2 (-4.0, 8.5)
Expressive language -0.4 (-6.3, 5.6) -1.6 (-7.6, 4.4) 4.7 (-2.4, 11.9) 3.6 (-3.6, 10.8)
Composite -0.3 (-9.5, 8.8) -1.3 (-10.3, 7.7) 8.2 (-2.6, 19.1) 6.1 (-4.3, 16.5)
AA, arachidonic acid; CI, confidence interval; DHA, docosahexaenoic acid. *Unadjusted models include a variable for laboratory.
†Beta coefficient represents a change in fatty acid concentration of 1.0%. ‡Adjusted models include laboratory, infant sex, parity, smoking and
preterm status.
Table 4. Results from linear regression models for the association between docosahexaenoic acid and arachidonic acid in breast milk and infant
formula weighted by feeding method for the first 4 post-natal months and Mullen Scales of Early Learning scores, PIN 2001–2006 [from PIN
(1995–2006)] Babies Study (n = 266)
Mullen Scales of Early
Learning
DHA in breast milk and formula (continuous) AA in breast milk and formula (continuous)
b (CI) (unadjusted)*† b (CI) (adjusted)‡ b (CI) (unadjusted)*† b (CI) (adjusted)‡
Gross motor 1.3 (-0.7, 3.2) 1.1 (-0.9, 3.1) 1.4 (-0.9, 3.6) 1.2 (-1.1, 3.4)
Visual reception -0.2 (-2.0, 1.7) -0.1 (-2.0, 1.8) 0.8 (-1.3, 2.8) 0.7 (-1.3, 2.8)
Fine motor 0.5 (-1.4, 2.3) 0.2 (-1.7, 2.0) 0.3 (-1.7, 2.4) 0.0 (-2.0, 2.0)
Receptive language 0.3 (-1.0, 1.5) -0.1 (-1.4, 1.2) 0.4 (-1.0, 1.9) 0.3 (-1.2, 1.7)
Expressive language -0.2 (-1.6, 1.2) -0.6 (-2.1, 0.8) 1.0 (-0.6, 2.7) 0.7 (-0.9, 2.3)
Composite -0.0 (-2.3, 2.2) -0.5 (-2.7, 1.7) 1.2 (-1.3, 3.7) 0.9 (-1.5, 3.4)
AA, arachidonic acid; CI, confidence interval; DHA, docosahexaenoic acid. *Unadjusted models include a variable for laboratory. †Beta
coefficient represents a change in fatty acid concentration of 1.0%. ‡Adjusted models include laboratory, feeding method for the first four
post-natal months, infant sex, parity, smoking, education, race/ethnicity and preterm status.
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Discussion
Infants who were exclusively or almost exclusively
breastfed for the first 4 months exhibited more
advanced development at 12 months on several
Mullen scales than exclusively formula-fed infants,
but estimates were attenuated after controlling for
key confounders and were no longer statistically
significant. This suggests that factors associated
with breastfeeding, rather than the composition of
breast milk, may contribute to positive associations
previously reported. Other studies have reported
similar null associations (Rogan & Gladen 1993;
Innis et al. 1996), but some contrast our findings,
noting enhanced development among breastfed
infants (Morrow-Tlucak et al. 1988; Temboury et al.
1994; Vestergaard et al. 1999; Agostoni et al. 2001;
Pinelli et al. 2003; Caspi et al. 2007). Differences
among studies may stem from differences in control
for confounders and in the developmental tests
used.
In our breast milk models, LCPUFA concentration
was unrelated to development, given the small mag-
nitude of the associations observed for DHA and the
CI that included the null for the models for AA. The
mean DHA and AA concentrations in our milk
samples were similar to those from other US studies
(Birch et al. 1998). A strength of this analysis is that
by restricting to exclusively breastfed children, one
avoids confounding from the choice of feeding
method; this is one way this study contributes to the
literature. Most studies of breast milk DHA have
been maternal supplementation trials, and results
have been equivocal (Gibson et al. 1997; Helland et al.
2001; Jensen et al. 2005; Lauritzen et al. 2005; Tofail
et al. 2006; Judge et al. 2007). Studies could have null
results because some developmental assessments may
be insensitive to the effects of DHA, because intent-
to-treat analyses were hindered by natural variability
in DHA and AA within treatment groups from diet or
other factors or because DHA and AA are simply not
associated with development. Our observational
study evaluated associations across the natural distri-
bution of DHA and AA to ascertain whether differ-
ences might be detectable in these exposure ranges, as
most US infants would have similar levels of exposure
as those in this study.To our knowledge, this is the first
study to take this approach. This study also contrib-
utes to the literature in its choice of developmental
assessment tool – the Mullen distinguishes five devel-
opmental domains rather than assessing development
globally.
Our models incorporating the DHA and AA con-
centration of breast milk with the DHA and AA
concentration of formulas showed no association
between the constructed exposure variables and
development. We are aware of no previous studies
that incorporated information about changing
feeding methods across time with LCPUFA exposure
from multiple sources. This exposure assessment
method may better reflect the reality of feeding,
where feeding methods and formula choices change
over time.
Several weaknesses underlie our findings. First,
very few infants were fed only formulas without DHA
and AA for all 4 months to compare with infants fed
only formulas with DHA and AA (although many
infants were fed unsupplemented formulas for
1–3 months). Second, although our results reflect
infants with a range of DHA exposure, reflecting
some very low and very high concentrations (for
example, 16 milk samples had <0.10% of total fatty
acids as DHA and 26 had >0.50%), and this range is
relatively wide compared with the exposures assigned
by most formula trials, these measures may conceal
associations at very high or very low exposure levels.
Again, the participants in this observational study
were free to choose any infant feeding method and
maternal diet, so the fact that we observed mostly null
results suggests that at the exposure levels in popula-
tions similar to this one, infants are unlikely to expe-
rience significant benefit from DHA. Third, the
imprecise confidence limits reflect our limited partici-
pant sample size. However, even among more precise
associations, most effect estimates were small or null.
In addition, we observed differences in the distribu-
tions of LCPUFA concentrations between laborato-
ries; these differences may affect interpretation of
summary statistics (e.g. median) but should not affect
the results of regression models.We adjusted for labo-
ratory in all models to control for differences.Also, no
participant characteristics varied by laboratory.
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Our method of assessing exposure by combining
breast milk and formula sources is novel but required
some simplifying assumptions. We had to assume that
breast milk composition was constant across lacta-
tion, and we could not quantify the amount of alpha-
linolenic acid in all formula products to estimate
its contribution to the total available DHA. Also, we
could not quantify the volume of milk or formula
consumed; this is also a limitation of other studies
that did not have information about volume. Around
4 months, some infants began receiving other foods
which could be a source of LCPUFAs; however,
typical baby foods were not a significant DHA source
at the time of this study. Unless mixed with formula or
breast milk, baby foods that replace milk or formula
could reduce LCPUFA exposure. The accuracy of
exposure measurement beyond 4 months of age may
differ by the amount of solids fed, which could differ
by initial feeding method, a problem for this study, as
well as for trials that do not prescribe infant diet once
solids are introduced.To minimize bias from differen-
tial exposure misclassification, we compared exposure
for only the first 4 months. Assessing diet during this
period precedes brain development at 12 months,
which allows time biologically for DHA to influence
the developing brain.
This study has strength in its ability to describe the
association between real-life feeding patterns and
development. We evaluated infant development as it
relates to the process of breastfeeding, the LCPUFA
content of breast milk among exclusive breastfeeders,
and the LCPUFA content of breast milk and formula
combined, regardless of source. Most research in this
area has been of randomized design supplement-
ing either breastfeeding women or formulas. While
proper randomization is an effective means of con-
trolling confounding, if a non-randomized breastfed
group is compared with the randomized formula-fed
group(s), confounding by factors that underlie the
choice about whether to breastfeed or to formula feed
remains an issue. Randomized studies are especially
good for investigating higher doses, but there is also
selectivity among those who enter trials and are com-
pliant with the protocols. This may affect the general-
izability of the findings. We evaluated and controlled
for many factors that underlie the choice of feeding
method and did not select participants based on
feeding method. Most randomized studies employ
intent-to-treat analysis, a powerful technique, but
intent-to-treat analysis assumes exposure is fixed
within the treatment group and constant across the
treatment period, which obscures the natural varia-
tion in most infants’ diets.The observational design of
this study enabled us to assess the impact of natural
variability in DHA and AA in the population, stem-
ming from variability in breast milk and formula con-
centrations, with extensive control for confounding.
Finally, it is possible that the Mullen may not detect
subtle physiologic benefits from LCPUFAs. Most pre-
vious studies reporting positive associations between
LCPUFAs and infant development have focused
on global development, but some have focused on
more specific aspects like achievement of gross motor
milestones and language ability (Auestad et al. 2001;
Agostoni et al. 2009). While the Mullen composite
correlates strongly with the original Bayley Mental
Development Index (correlations range 0.53–0.59)
and moderately with the Psychomotor Development
Index (correlations range 0.21–0.52), the Mullen sub-
scales correspond to five specific developmental
domains that are assessed together, allowing us to
evaluate associations with particular domains that
might be masked in a broader global measure that
cannot detect uneven cognitive development (Mullen
1995). No previous studies in this area have used the
Mullen.
Conclusion
After careful adjustment for confounding, neither the
exclusivity of breastfeeding nor DHA andAA concen-
trations in breast milk and formula were associated
with visual reception, language and motor skills, and
overall cognitive development among infants at
12 months in this study. It remains possible that the
effects of LCPUFAs are limited to certain outcomes
like visual acuity or that lasting effects do not become
apparent until after infancy. While supplementation
trials are better suited to evaluating the effects of
heavy LCPUFA supplementation or deficiency, this
observational study design met our goal of evaluating
natural variability in DHA and AA derived from
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population variability in milk concentration and
formula use. Future studies of LCPUFA exposure and
infant development should consider individual expo-
sures using the actual concentrations of fatty acids in
milk, as a complement to analyses that compare treat-
ment groups.
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